Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome

Clinical trial NCT00788073 · COMPLETED

Trial details

NCT number: NCT00788073
Sponsor: Seaside Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2008-11-01
Primary completion: 2010-03-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.